Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions (Q34576340)

3 August 2017

1 reference

title

Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions (English)

1 reference

3 August 2017

0 references

0 references

Klein E

1

1 reference

3 August 2017

Kis LL

series ordinal

2

1 reference

3 August 2017

Klein G

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

3 August 2017

1 reference

3 August 2017

26

1 reference

3 August 2017

9

1 reference

3 August 2017

1297-1305

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210240

3 August 2017

0 references

cites work

Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

EBV persistence in memory B cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus strategy in normal and neoplastic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Molecular biology of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Chromosomal translocations deregulating c-myc are associated with normal immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus: exploiting the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

B-cell chronic lymphocytic leukemia: a bird of a different feather

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Clonality and methylation status of the epstein-barr virus (EBV) genomes in IN V7W-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Classification and biological nature of established human hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Activation and immortalization of leukaemic B cells by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210240

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210240

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference